ZLAB Stock Analysis: Buy, Sell, or Hold?
ZLAB - Zai Lab Limited American Depositary Shares
$20.36
-0.14 (-0.68%)
▼
5d:
+14.06%
30d:
+4.2%
90d:
+12.55%
BUY
MODERATE Confidence
Analysis Updated: Apr 6, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When ZLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ZLAB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ZLAB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ZLAB is currently trading at $20.36, which is considered extended relative to its 30-day fair value range of $18.06 to $19.49.
Technical Outlook: Technically, ZLAB is in a downtrend. The price is approaching resistance at $20.78. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZLAB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $38.47 (+87.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZLAB is in a downtrend. The price is approaching resistance at $20.78. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZLAB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $38.47 (+87.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$18.06 -
$19.49
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 87.6% below Wall St target ($38.47)
Fair Price Analysis
30-Day Fair Range
$18.06 -
$19.49
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$17.33
Resistance Level
$20.78
Current Trend
Downtrend
Technical data as of
Apr 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.68
Wall Street Target
$38.47
(+87.6%)
Revenue Growth (YoY)
17.0%
Profit Margin
-38.1%
Share & Embed Analysis
Last updated: April 07, 2026 10:34 AM ET
Data refreshes hourly during market hours. Next update: 11:34 AM
Data refreshes hourly during market hours. Next update: 11:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZLAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Rafael Amado
SELL
2957 shares
2026-03-13
Yajing Chen
SELL
1703 shares
2026-03-13
Joshua L Smiley
SELL
1966 shares
2026-03-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 61 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 64 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 59 HOLD |
